MedTrace Logo

Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.

NCT06087796 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-10-18

No results posted yet for this study

Summary

To compare the efficacy and safety of topical pentoxifylline 2% gel and topical metformin 10% gel versus topical betamethasone valerate 0.1% cream, in treatment of patchy alopecia areata.

Conditions

Interventions

DRUG

Betamethasone Valerate 0.1% Cream

Topical treatment modality for alopecia areata.

DRUG

Pentoxifylline

Topical treatment modality for alopecia areata.

DRUG

Metformin

Topical treatment modality for alopecia areata.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Nada K. Mostafa, bachelor · Assuit university hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-31
Primary Completion
2024-09-30
Completion
2024-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06087796 on ClinicalTrials.gov